Fierce Pharma55 分钟
As Humira succession plan played out, AbbVie's Rob Michael collected $18.5M in his first ...
While Humira’s 2023 loss of exclusivity hung over AbbVie’s head for years, the ascent of the Chicago drugmaker’s immunology successors Skyrizi and Rinvoq under prior CEO Richard Gonzalez has swiftl | ...